Leonie van Passel
Neurology · Sarasota, FLNPI 1760454524
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.2%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Eisai Inc. at 53.0% of the total. Reporting peaked in 2021 at $2,895 and has fallen 95.6% since, to $129 in 2024.
Across 198 payments — averaging $43.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$5K
- UCB, Inc.$606
- Sunovion Pharmaceuticals Inc.$420
- SK Life Science, Inc.$353
- Amgen$330
- Jazz Pharmaceuticals Inc.$322
- plus $2K from 24 others
What the payments were for
- Consulting fees$4,18548%
- Speaking & faculty fees$370%
- Food & beverage$4,42851%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 16 | $4,584 |
| UCB, Inc. | 14 | $606 |
| Sunovion Pharmaceuticals Inc. | 17 | $420 |
| SK Life Science, Inc. | 14 | $353 |
| Amgen | 18 | $330 |
| Jazz Pharmaceuticals Inc. | 17 | $322 |
| Novartis | 33 | $310 |
| AbbVie(2 entities) | 20 | $293 |
| Livanova USA, Inc. | 3 | $248 |
| Lilly USA, LLC | 7 | $141 |
| Greenwich Biosciences, Inc. | 2 | $138 |
| Neuropace, Inc. | 1 | $120 |
| Harmony Biosciences LLC | 3 | $92 |
| Biohaven Pharmaceuticals, Inc. | 2 | $82 |
| Merck | 4 | $77 |
| Lundbeck LLC | 4 | $76 |
| Supernus Pharmaceuticals, Inc. | 3 | $60 |
| Neurelis, Inc. | 3 | $56 |
| EMD Serono, Inc. | 3 | $53 |
| Acadia Pharmaceuticals Inc | 2 | $41 |
| Centinel Spine, LLC | 1 | $39 |
| Acorda Therapeutics, Inc | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Amneal Pharmaceuticals LLC | 1 | $31 |
| Merz Pharmaceuticals, LLC | 1 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Resmed Corp | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Genentech USA, Inc. | 1 | $13 |
| Zyla Life Sciences, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Briviact$253
- Fycompa$237
- APTIOM$237
- RNS System$120
- Epidiolex$104
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$102
How this compares
$8,650 in reported general payments places this provider in the 70th percentile of 1,434 neurology providers in Florida.
Other neurology in Sarasota
- Donald NegroskiSarasota$1.4M
- Julio CanteroSarasota$811K
- Victor KassiciehSarasota$318K
- Gregory HanesSarasota$255K
- Maurico ConchaSarasota$212K
- Stuart IsaacsonBoca Raton$3.9M
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
- David RoseTampa$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.